DAX23.499 -1,0%Est505.728 -0,7%MSCI World4.343 -0,1%Top 10 Crypto9,5000 -4,8%Nas22.360 -0,5%Bitcoin62.027 -3,3%Euro1,1517 -0,2%Öl109,3 +5,6%Gold4.865 -2,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Siemens Energy ENER6Y DroneShield A2DMAA Lufthansa 823212 Deutsche Telekom 555750 SAP 716460 Commerzbank CBK100 Allianz 840400 Deutsche Bank 514000 Volkswagen (VW) vz. 766403 Bayer BAY001 Infineon 623100 Shell (ex Royal Dutch Shell) A3C99G NEL ASA A0B733
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Vor Fed-Entscheid: DAX in Rot -- US-Börsen im Minus -- thyssenkrupp nucera: Großauftrag treibt Erwartungen -- SAP, Siemens Energy, Rüstungsaktien, Droneshield, Samsung, NVIDIA im Fokus
Top News
NEL-Aktie klettert: Berenberg senkt Kursziel, hebt aber neue Alkaline-Generation positiv hervor NEL-Aktie klettert: Berenberg senkt Kursziel, hebt aber neue Alkaline-Generation positiv hervor
Tech-Aktien profitieren: Samsung plant Chipverträge - NVIDIA erhält grünes Licht für H200-Chipverkäufe Tech-Aktien profitieren: Samsung plant Chipverträge - NVIDIA erhält grünes Licht für H200-Chipverkäufe
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Sparen mit Plan. Sparplan mit Bitcoin & 21shares
Wer­bung

Telix Pharmaceuticals Aktie

Kaufen
Verkaufen
7,15 EUR -0,15 EUR -2,05 %
FSE
8,58 USD +0,27 USD +3,24 %
BTT
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone
Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA40FCQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS87961M1053

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTLX

Telix Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswireTelix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
PR NewswireDEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class Actions
PR NewswireTELIX PHARMACEUTICALS (NASDAQ: TLX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 9, 2026
PR NewswireTelix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswirePrecision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
PR NewswireNASDAQ: TLX INVESTOR ALERT: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors of a January 9, 2026 Deadline
PR NewswireTelix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
PR NewswireCLASS ACTION NOTICE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action
PR NewswireProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed
PR NewswireATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit
PR NewswireTelix Pharmaceuticals Ltd. Shareholders with Large Losses Should Contact Robbins LLP for Information About the TLX Class Action
PR NewswireTelix Opens TMS Yokohama in Japan, Commemorative Lecture Held
PR NewswireZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses
PR NewswireBerger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
PR NewswireShareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately
PR NewswireTLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireBerger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
PR NewswireOPALESCENCE Trial Published in EJNMMI: Confirms Theranostic Potential of TLX250-CDx in Breast Cancer
PR NewswireTLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
PR NewswireRosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
PR NewswireTLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging
PR NewswireTelix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
PR NewswireTelix Reports US$206M Revenue, FY 2025 Guidance Upgraded
PR NewswireRosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
PR NewswireTelix Announces Record-Breaking Presence at EANM 2025
PR NewswireTelix Doses First Patient in Phase 3 BiPASS Trial: PSMA-PET Imaging for Prostate Cancer Diagnosis
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireTelix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX
PR NewswireTelix H1 2025 Results: Investor Webcast Notification
PR NewswireTelix Reports $204M Revenue, Up 63% YOY
PR NewswireProstatakrebs-PSMA-PET-Bildgebungsmittel Illuccix® in Österreich zugelassen
PR NewswireGozellix Receives Permanent HCPCS Code
PR NewswireTelix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses
PR NewswireIlluccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Greece
PR NewswireTelix's Illuccix® PSMA-PET Imaging Agent Approved in Germany

Telix Pharmaceuticals News

Telix Pharmaceuticals News: auf dieser Seite finden Sie alle Telix Pharmaceuticals News und Nachrichten zur Telix Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Telix Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Telix Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.